Literature DB >> 21537348

The population genetics of chronic kidney disease: insights from the MYH9-APOL1 locus.

Saharon Rosset1, Shay Tzur, Doron M Behar, Walter G Wasser, Karl Skorecki.   

Abstract

Many rare kidney disorders exhibit a monogenic, Mendelian pattern of inheritance. Population-based genetic studies have identified many genetic variants associated with an increased risk of developing common kidney diseases. Strongly associated variants have potential clinical uses as predictive markers and may advance our understanding of disease pathogenesis. These principles are elegantly illustrated by a region within chromosome 22q12 that has a strong association with common forms of kidney disease. Researchers had identified DNA sequence variants in this locus that were highly associated with an increased prevalence of common chronic kidney diseases in people of African ancestry. Initial research concentrated on MYH9 as the most likely candidate gene; however, population-based whole-genome analysis enabled two independent research teams to discover more strongly associated mutations in the neighboring APOL1 gene. The powerful evolutionary selection pressure of an infectious pathogen in West Africa favored the spread of APOL1 variants that protect against a lethal form of African sleeping sickness but are highly associated with an increased risk of kidney disease. We describe the data sources, process of discovery, and reasons for initial misidentification of the candidate gene, as well as the lessons that can be learned for future population genetics research.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21537348     DOI: 10.1038/nrneph.2011.52

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


  145 in total

1.  Potential etiologic and functional implications of genome-wide association loci for human diseases and traits.

Authors:  Lucia A Hindorff; Praveen Sethupathy; Heather A Junkins; Erin M Ramos; Jayashri P Mehta; Francis S Collins; Teri A Manolio
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-27       Impact factor: 11.205

Review 2.  Allelic association: linkage disequilibrium structure and gene mapping.

Authors:  Andrew Collins
Journal:  Mol Biotechnol       Date:  2008-10-08       Impact factor: 2.695

3.  Individual genomes on the horizon.

Authors:  Richard P Lifton
Journal:  N Engl J Med       Date:  2010-03-10       Impact factor: 91.245

4.  Apolipoprotein L-I is the trypanosome lytic factor of human serum.

Authors:  Luc Vanhamme; Françoise Paturiaux-Hanocq; Philippe Poelvoorde; Derek P Nolan; Laurence Lins; Jan Van Den Abbeele; Annette Pays; Patricia Tebabi; Huang Van Xong; Alain Jacquet; Nicole Moguilevsky; Marc Dieu; John P Kane; Patrick De Baetselier; Robert Brasseur; Etienne Pays
Journal:  Nature       Date:  2003-03-06       Impact factor: 49.962

Review 5.  The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans.

Authors:  Barry I Freedman; Jeffrey B Kopp; Carl D Langefeld; Giulio Genovese; David J Friedman; George W Nelson; Cheryl A Winkler; Donald W Bowden; Martin R Pollak
Journal:  J Am Soc Nephrol       Date:  2010-08-05       Impact factor: 10.121

6.  Admixture mapping of end stage kidney disease genetic susceptibility using estimated mutual information ancestry informative markers.

Authors:  Liran I Shlush; Sivan Bercovici; Walter G Wasser; Guennady Yudkovsky; Alan Templeton; Dan Geiger; Karl Skorecki
Journal:  BMC Med Genomics       Date:  2010-10-18       Impact factor: 3.063

7.  Racial differences in end-stage renal disease rates in HIV infection versus diabetes.

Authors:  Andy I Choi; Rudolph A Rodriguez; Peter Bacchetti; Daniel Bertenthal; Paul A Volberding; Ann M O'Hare
Journal:  J Am Soc Nephrol       Date:  2007-10-17       Impact factor: 10.121

8.  Pathology of HIV-associated nephropathy: a detailed morphologic and comparative study.

Authors:  V D'Agati; J I Suh; L Carbone; J T Cheng; G Appel
Journal:  Kidney Int       Date:  1989-06       Impact factor: 10.612

9.  Only the serum-resistant bloodstream forms of Trypanosoma brucei rhodesiense express the serum resistance associated (SRA) protein.

Authors:  C De Greef; E Chimfwembe; J Kihang'a Wabacha; E Bajyana Songa; R Hamers
Journal:  Ann Soc Belg Med Trop       Date:  1992

Review 10.  Human innate immunity against African trypanosomes.

Authors:  Etienne Pays; Benoit Vanhollebeke
Journal:  Curr Opin Immunol       Date:  2009-06-24       Impact factor: 7.486

View more
  38 in total

Review 1.  ApoL1 and the Immune Response of Patients with Systemic Lupus Erythematosus.

Authors:  Ashira D Blazer; Robert M Clancy
Journal:  Curr Rheumatol Rep       Date:  2017-03       Impact factor: 4.592

2.  APOL1 variants associate with increased risk of CKD among African Americans.

Authors:  Meredith C Foster; Josef Coresh; Myriam Fornage; Brad C Astor; Morgan Grams; Nora Franceschini; Eric Boerwinkle; Rulan S Parekh; W H Linda Kao
Journal:  J Am Soc Nephrol       Date:  2013-06-13       Impact factor: 10.121

Review 3.  Race in biological and biomedical research.

Authors:  Richard S Cooper
Journal:  Cold Spring Harb Perspect Med       Date:  2013-11-01       Impact factor: 6.915

Review 4.  Genetic variation and adaptation in Africa: implications for human evolution and disease.

Authors:  Felicia Gomez; Jibril Hirbo; Sarah A Tishkoff
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-07-01       Impact factor: 10.005

5.  APOL1 variants and kidney disease in people of recent African ancestry.

Authors:  Giulio Genovese; David J Friedman; Martin R Pollak
Journal:  Nat Rev Nephrol       Date:  2013-02-26       Impact factor: 28.314

Review 6.  Addressing the global burden of chronic kidney disease through clinical and translational research.

Authors:  Akinlolu Ojo
Journal:  Trans Am Clin Climatol Assoc       Date:  2014

Review 7.  The African diaspora: history, adaptation and health.

Authors:  Charles N Rotimi; Fasil Tekola-Ayele; Jennifer L Baker; Daniel Shriner
Journal:  Curr Opin Genet Dev       Date:  2016-09-16       Impact factor: 5.578

8.  Risk factors for ESRD in HIV-infected individuals: traditional and HIV-related factors.

Authors:  Vasantha Jotwani; Yongmei Li; Carl Grunfeld; Andy I Choi; Michael G Shlipak
Journal:  Am J Kidney Dis       Date:  2011-12-28       Impact factor: 8.860

Review 9.  Genomics in CKD: Is This the Path Forward?

Authors:  Girish N Nadkarni; Carol R Horowitz
Journal:  Adv Chronic Kidney Dis       Date:  2016-03       Impact factor: 3.620

Review 10.  The biology of APOL1 with insights into the association between APOL1 variants and chronic kidney disease.

Authors:  Sethu M Madhavan; John F O'Toole
Journal:  Clin Exp Nephrol       Date:  2014-04       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.